Women’s Wear Daily
04.19.2014

Financial

Beauty

Financial

Page 6 of 1326

Coty's Q2 Results Show Challenging Quarter

The company's profits and revenues fell in the quarter.

Avon Inching Closer to SEC Settlement

The company said it may be getting closer to reaching a settlement related to the ongoing Foreign Corrupt Practices Act investigations.

Nestlé, L’Oréal, Nestle, L'oreal, Loreal, stake, shares, sale, Galderma, Bettencourt Meyers, Jean-Paul Agon,

Nestlé to Reduce Stake in L'Oréal to 23.3%

The beauty firm plans to buy 48.5 million of its shares from Nestlé, boosting the stake held by the Bettencourt Meyers family to 33.31 percent.

L'Oréal to Buy 8% of Share Capital From Nestlé

The French beauty giant is to fund the operation by disposing its 50 percent stake in Galderma.

L’Oréal Shares Climb on Nestlé Reports

The Swiss company is said to be looking at ways to reduce its 23.9 percent stake in the French beauty giant.

B&B Capital Partners LP Acquires Aromatherapy Associates

The British beauty brand is known for its aromatherapy-based skin-care and body-care ranges.

Estée Lauder Plots Growth in Emerging Markets

Beauty firm is increasingly taking a global view in 2014.

Newsletters
Newsletters

Sign upSign up for WWD and FN newsletters to receive daily headlines, breaking news alerts and weekly industry wrap-ups.

Publications

ArticleFinder

Beauty


Choose By

Clear

How it works

Close

Lorem Ipsum
Dolor sit amet, consectetur adipiscing elit. Vivamus ac nibh et risus lobortis scelerisque tempor nec enim. Etiam facilisis sapien sit amet.

Lorem Ipsum
Dolor sit amet, consectetur adipiscing elit. Vivamus ac nibh et risus lobortis scelerisque tempor nec enim. Etiam facilisis sapien sit amet.

Lorem Ipsum
Dolor sit amet, consectetur adipiscing elit. Vivamus ac nibh et risus lobortis scelerisque tempor nec enim. Etiam facilisis sapien sit amet.

Lorem Ipsum
Dolor sit amet, consectetur adipiscing elit. Vivamus ac nibh et risus lobortis scelerisque tempor nec enim. Etiam facilisis sapien sit amet.

Lorem Ipsum
Dolor sit amet, consectetur adipiscing elit. Vivamus ac nibh et risus lobortis scelerisque tempor nec enim. Etiam facilisis sapien sit amet.


Or